Reuters logo
BRIEF-Lupin's Aurangabad facility gets 8 observations from USFDA during April inspection
May 9, 2017 / 10:53 AM / 6 months ago

BRIEF-Lupin's Aurangabad facility gets 8 observations from USFDA during April inspection

May 9 (Reuters) - Lupin Ltd

* Lupin ltd clarifies on news item “USFDA issues 8 observations for Aurangabad plant”

* Says co’s Aurangabad facility underwent an inspection by US FDA subsequent to which US FDA issued form 483 citing 8 observations

* Says co in process of addressing these observations Source text: (bit.ly/2pqN2vW) Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below